(Q39052398)

8 September 2017

title

Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells (English)

1 reference

8 September 2017

1 reference

1 reference

Jin-Quan Wang

1

1 reference

8 September 2017

Ping-Yu Zhang

2

1 reference

8 September 2017

Chen Qian

3

1 reference

8 September 2017

Xiao-Juan Hou

4

1 reference

8 September 2017

Liang-Nian Ji

5

1 reference

8 September 2017

Hui Chao

6

1 reference

8 September 2017

publication date

28 November 2013

1 reference

Journal of Biological Inorganic Chemistry

8 September 2017

published in

1 reference

8 September 2017

volume

19

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

335-348

1 reference

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Platinum Compounds: a New Class of Potent Antitumour Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Cisplatin-based therapy: a neurological and neuropsychological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

New trends for metal complexes with anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Recent developments in the field of anticancer platinum complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Ruthenium complexes as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Metal complexes as DNA intercalators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Ruthenium(II) metallo-intercalators: DNA imaging and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Cellular uptake, cytotoxicity, and metabolic profiling of human cancer cells treated with ruthenium(II) polypyridyl complexes [Ru(bpy)2(N--N)]Cl2 with N--N=bpy, phen, dpq, dppz, and dppn

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Exploring biologically relevant chemical space with metal complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Chiral ruthenium(II) complexes with phenolic hydroxyl groups as dual poisons of topoisomerases I and IIα.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Targeting mitochondria with organelle-specific compounds: strategies and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Mitochondria in cancer cells: what is so special about them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Mitochondrial membrane permeabilization in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Targeting mitochondria for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Ruthenium complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Molecular and cellular characterization of the biological effects of ruthenium(II) complexes incorporating 2-pyridyl-2-pyrimidine-4-carboxylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Selective mitochondrial accumulation of cytotoxic dinuclear polypyridyl ruthenium(II) complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Responsive and mitochondria-specific ruthenium(II) complex for dual in vitro applications: two-photon (near-infrared) induced imaging and regioselective cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Mechanism of cytotoxicity and cellular uptake of lipophilic inert dinuclear polypyridylruthenium(II) complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Discovery of a strongly apoptotic ruthenium complex through combinatorial coordination chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Ruthenium polypyridyl complexes that induce mitochondria-mediated apoptosis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Ruthenium methylimidazole complexes induced apoptosis in lung cancer A549 cells through intrinsic mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Phosphorescent light-emitting iridium complexes serve as a hypoxia-sensing probe for tumor imaging in living animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Live cell luminescence imaging as a function of delivery mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Manganese(III)-salens induce tumor selective apoptosis in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Real-time flow cytometry analysis of permeability transition in isolated mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

MFTZ-1, an actinomycetes subspecies derived antitumor macrolide, functions as a novel topoisomerase II poison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

VP1686, a Vibrio type III secretion protein, induces toll-like receptor-independent apoptosis in macrophage through NF-kappaB inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Iron(III)-salen damages DNA and induces apoptosis in human cell via mitochondrial pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Oxidants, antioxidants, and the degenerative diseases of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Molecular mechanisms of N-acetylcysteine actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Synthesis, structures, cellular uptake and apoptosis-inducing properties of highly cytotoxic ruthenium-Norharman complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Mitochondrial intermembrane proteins in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Nuclear permeable ruthenium(II) β-carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Mitochondria and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Copper-dependent cytotoxicity of 8-hydroxyquinoline derivatives correlates with their hydrophobicity and does not require caspase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

The Bcl-2-regulated apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Ruthenium Anticancer Compounds: Challenges and Expectations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-013-1069-2

Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition

21 January 2018

1 reference

12 December 2020

KP1019 (FFC14A) from bench to bedside: preclinical and early clinical development--an overview.

1 reference

12 December 2020

Luminescent ruthenium(II) polypyridyl functionalized gold nanoparticles; their DNA binding abilities and application as cellular imaging agents

1 reference

12 December 2020

From DNA damage to G2 arrest: the many roles of topoisomerase II

1 reference

12 December 2020

Enantiomeric ruthenium(II) complexes binding to DNA: binding modes and enantioselectivity

1 reference

12 December 2020

Synthesis, characterization, and DNA-binding studies of ruthenium complexes [Ru(tpy)(ptn)]2+ and Ru(dmtpy)(ptn)]2+

1 reference

12 December 2020

Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model

1 reference

12 December 2020

Release of NO from a nitrosyl ruthenium complex through oxidation of mitochondrial NADH and effects on mitochondria

1 reference

12 December 2020

10.1007/S00775-013-1069-2

Identifiers

DOI

1 reference

8 September 2017

1 reference